ID

36853

Description

Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02064582

Lien

https://clinicaltrials.gov/show/NCT02064582

Mots-clés

Versions (1)
  1. 16/06/2019 16/06/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

16 juin 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT02064582

Anglais

Eligibility Prostate Cancer NCT02064582

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven adenocarcinoma of the prostate within 6 months of screening
Description

Adenocarcinoma of prostate

Type de données

boolean

Alias
UMLS CUI [1]
C0007112
eastern cooperative oncology group(ecog) score 0-2
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
adequate organ and and blood marrow function
Description

Organ function | Hematologic function

Type de données

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2]
C0221130
must be a candidate for long-term androgen deprivation in combination with external beam radiation for the treatment of high risk prostate cancer
Description

Antiandrogen therapy Long-term | External Beam Radiation Therapy | Combined Modality Therapy High risk Prostate carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0279492
UMLS CUI [1,2]
C0443252
UMLS CUI [2]
C1517033
UMLS CUI [3,1]
C0009429
UMLS CUI [3,2]
C4319571
UMLS CUI [3,3]
C0600139
patient must permit a targeted prostate biopsy at the time of study initiation or at the beginning of radiation treatment
Description

Biopsy of prostate Targeted

Type de données

boolean

Alias
UMLS CUI [1,1]
C0194804
UMLS CUI [1,2]
C1521840
men who are sexually active with female partners of child-bearing potential mush agree to use adequate contraception
Description

Gender Partner in relationship Childbearing Potential | Gender Sexually active Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0682323
UMLS CUI [1,3]
C3831118
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0241028
UMLS CUI [2,3]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment with agents known to have endocrine effects on prostate cancer
Description

Pharmacotherapy Endocrine effects Prostate carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0678896
UMLS CUI [1,3]
C0600139
treatment with corticosteroids within 4 weeks of enrollment
Description

Adrenal Cortex Hormones

Type de données

boolean

Alias
UMLS CUI [1]
C0001617
treatment with androgens within 6 months of enrollment
Description

Androgen therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0279493
may not be receiving any other investigational agents
Description

Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
prostate specific antigen greater than 160ng/dl
Description

Prostate specific antigen measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0201544
history of malignancy( other than non-melanoma skin cancer) within 5 years
Description

Malignant Neoplasms | Exception Skin carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
uncontrolled intercurrent illness
Description

Comorbidity Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
cardiovascular event within 6 months of enrollment
Description

Cardiovascular event

Type de données

boolean

Alias
UMLS CUI [1]
C1320716
seizure or seizure disorder history
Description

Seizure | Epilepsy

Type de données

boolean

Alias
UMLS CUI [1]
C0036572
UMLS CUI [2]
C0014544
contraindications to mri- pacemakers, clips, etc
Description

Medical contraindication MRI | Artificial cardiac pacemaker | Clips

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0024485
UMLS CUI [2]
C0030163
UMLS CUI [3]
C0175722
Retour au début de la page

Similar models

Eligibility Prostate Cancer NCT02064582

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
histologically proven adenocarcinoma of the prostate within 6 months of screening
boolean
C0007112 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group(ecog) score 0-2
boolean
C1520224 (UMLS CUI [1])
Organ function | Hematologic function
Item
adequate organ and and blood marrow function
boolean
C0678852 (UMLS CUI [1])
C0221130 (UMLS CUI [2])
Antiandrogen therapy Long-term | External Beam Radiation Therapy | Combined Modality Therapy High risk Prostate carcinoma
Item
must be a candidate for long-term androgen deprivation in combination with external beam radiation for the treatment of high risk prostate cancer
boolean
C0279492 (UMLS CUI [1,1])
C0443252 (UMLS CUI [1,2])
C1517033 (UMLS CUI [2])
C0009429 (UMLS CUI [3,1])
C4319571 (UMLS CUI [3,2])
C0600139 (UMLS CUI [3,3])
Biopsy of prostate Targeted
Item
patient must permit a targeted prostate biopsy at the time of study initiation or at the beginning of radiation treatment
boolean
C0194804 (UMLS CUI [1,1])
C1521840 (UMLS CUI [1,2])
Gender Partner in relationship Childbearing Potential | Gender Sexually active Contraceptive methods
Item
men who are sexually active with female partners of child-bearing potential mush agree to use adequate contraception
boolean
C0079399 (UMLS CUI [1,1])
C0682323 (UMLS CUI [1,2])
C3831118 (UMLS CUI [1,3])
C0079399 (UMLS CUI [2,1])
C0241028 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Pharmacotherapy Endocrine effects Prostate carcinoma
Item
prior treatment with agents known to have endocrine effects on prostate cancer
boolean
C0013216 (UMLS CUI [1,1])
C0678896 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
Adrenal Cortex Hormones
Item
treatment with corticosteroids within 4 weeks of enrollment
boolean
C0001617 (UMLS CUI [1])
Androgen therapy
Item
treatment with androgens within 6 months of enrollment
boolean
C0279493 (UMLS CUI [1])
Investigational New Drugs
Item
may not be receiving any other investigational agents
boolean
C0013230 (UMLS CUI [1])
Prostate specific antigen measurement
Item
prostate specific antigen greater than 160ng/dl
boolean
C0201544 (UMLS CUI [1])
Malignant Neoplasms | Exception Skin carcinoma
Item
history of malignancy( other than non-melanoma skin cancer) within 5 years
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
Comorbidity Uncontrolled
Item
uncontrolled intercurrent illness
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Cardiovascular event
Item
cardiovascular event within 6 months of enrollment
boolean
C1320716 (UMLS CUI [1])
Seizure | Epilepsy
Item
seizure or seizure disorder history
boolean
C0036572 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
Medical contraindication MRI | Artificial cardiac pacemaker | Clips
Item
contraindications to mri- pacemakers, clips, etc
boolean
C1301624 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
C0030163 (UMLS CUI [2])
C0175722 (UMLS CUI [3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial